These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9658929)

  • 1. [Vitamin D induces proliferation in rat endometrium cultured cells].
    Delissalde F; Hernández MA; Barrón A; Bermejo L; Arias J; Halhali A; Castro I
    Rev Invest Clin; 1998; 50(2):113-8. PubMed ID: 9658929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25(OH)2D3 and dihydrotestosterone interact to regulate proliferation and differentiation of epiphyseal chondrocytes.
    Krohn K; Haffner D; Hügel U; Himmele R; Klaus G; Mehls O; Schaefer F
    Calcif Tissue Int; 2003 Oct; 73(4):400-10. PubMed ID: 12874696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
    Levy Y; Knutson JC; Bishop C; Shany S
    Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
    Murthy S; Agoulnik IU; Weigel NL
    Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth.
    Gavrilov V; Steiner M; Shany S
    Anticancer Res; 2005; 25(5):3425-9. PubMed ID: 16101159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-talk between vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling in melanoma cells.
    Sertznig P; Dunlop T; Seifert M; Tilgen W; Reichrath J
    Anticancer Res; 2009 Sep; 29(9):3647-58. PubMed ID: 19667161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,25 dihydroxyvitamin D3 enhances the calcium response of keratinocytes.
    Ratnam AV; Bikle DD; Cho JK
    J Cell Physiol; 1999 Feb; 178(2):188-96. PubMed ID: 10048583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of serum-stimulated mitogen activated protein kinase by 1alpha,25(OH)2-vitamin D3 in MCF-7 breast cancer cells.
    Capiati DA; Rossi AM; Picotto G; Benassati S; Boland RL
    J Cell Biochem; 2004 Oct; 93(2):384-97. PubMed ID: 15368364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of 1,25(OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88.
    Kunakornsawat S; Rosol TJ; Capen CC; Middleton RP; Hannah SS; Inpanbutr N
    Anticancer Res; 2001; 21(5):3355-63. PubMed ID: 11848494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
    Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of selective cyclooxygenase inhibitors on intestinal epithelial cell mitogenesis.
    Erickson BA; Longo WE; Panesar N; Mazuski JE; Kaminski DL
    J Surg Res; 1999 Jan; 81(1):101-7. PubMed ID: 9889067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
    Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
    Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of antimitogenic action of vitamin D in human colon carcinoma cells: relevance for suppression of epidermal growth factor-stimulated cell growth.
    Tong WM; Hofer H; Ellinger A; Peterlik M; Cross HS
    Oncol Res; 1999; 11(2):77-84. PubMed ID: 10489163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The anti-proliferative effects of 1alpha,25(OH)2D3 on breast and prostate cancer cells are associated with induction of BRCA1 gene expression.
    Campbell MJ; Gombart AF; Kwok SH; Park S; Koeffler HP
    Oncogene; 2000 Oct; 19(44):5091-7. PubMed ID: 11042697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
    Lu HQ; Zheng J
    Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat endometrial cells in primary culture: effects and interaction of sex hormones and vitamin D3 metabolite on alkaline phosphatase.
    Lieberherr M; Acker GM; Grosse B; Pesty A; Balsan S
    Endocrinology; 1984 Aug; 115(2):824-9. PubMed ID: 6086279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25-Hydroxycholesterol has a dual effect on the proliferation of cultured rat astrocytes.
    Velázquez E; Santos A; Montes A; Blázquez E; Ruiz-Albusac JM
    Neuropharmacology; 2006 Aug; 51(2):229-37. PubMed ID: 16678217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.
    Konety BR; Lavelle JP; Pirtskalaishvili G; Dhir R; Meyers SA; Nguyen TS; Hershberger P; Shurin MR; Johnson CS; Trump DL; Zeidel ML; Getzenberg RH
    J Urol; 2001 Jan; 165(1):253-8. PubMed ID: 11125420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.